Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

समान संसाधन

• Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease
  द्वारा: Dulai, Parambir S., और अन्य
  प्रकाशित: (2013)
• Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
  द्वारा: Afif, Waqqas, और अन्य
  प्रकाशित: (2010)
• Progress in the Diagnosis and Treatment of Inflammatory Bowel Disease
  द्वारा: Loftus, Edward V.
  प्रकाशित: (2011)
• Infliximab in inflammatory bowel disease
  द्वारा: Papamichael, Konstantinos, और अन्य
  प्रकाशित: (2019)
• The Present and Future of Inflammatory Bowel Disease Treatment
  द्वारा: Sandborn, William J.
  प्रकाशित: (2016)